Perfil
John Hunter formerly worked at XOMA Royalty Corp., as Senior Director, Compugen Ltd., as Chief Scientific Officer, Compugen, Inc. (United States), as Vice President-Antibody R&D, Keyhole Therapeutics, Inc., as Chief Executive & Scientific Officer, and FibroGen, Inc., as Chief Scientific Officer from 2021 to 2024.
Dr. Hunter received his undergraduate degree from Hartwick College and doctorate degree from The University of California, San Francisco.
Antiguos cargos conocidos de John Hunter.
| Empresas | Cargo | Fin |
|---|---|---|
| KYNTRA BIO, INC. | Director Técnico/Científico/I+D | 01/10/2024 |
| XOMA ROYALTY CORPORATION | Director/Miembro de la Junta | - |
Keyhole Therapeutics, Inc.
Keyhole Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a discovery stage drug company that specializes immunotherapies for cancer and autoimmune diseases | Director Ejecutivo | - |
| COMPUGEN LTD. | Director Técnico/Científico/I+D | - |
Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Formación de John Hunter.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Compugen Ltd.
Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
FibroGen, Inc.
FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Hartwick College
Hartwick College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compugen, Inc. (United States) | |
Keyhole Therapeutics, Inc.
Keyhole Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a discovery stage drug company that specializes immunotherapies for cancer and autoimmune diseases | Health Technology |
- Bolsa de valores
- Insiders
- John Hunter
















